Thursday, March 28, 2024 | Baltimore, MD
FOLLOW US:

Novavax secures CDC signoff for Covid-19 vaccine as booster

October 21, 2022

It’s a good week for Novavax. The Gaithersburg vaccine maker has earned the Centers for Disease Control and Prevention’s recommendation to make its protein-based shot available as a booster to adults in the U.S., the last hurdle required before people can use it beyond a primary series. The CDC said late Wednesday that its director, Dr. Rochelle Walensky, greenlit the decision — which gives initially vaccinated adults the choice to get Novavax’s jab as a booster instead of the updated Omicron-specific shots from Pfizer-BioNTech or Moderna.

Article Source: Washington Business Journal

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.